MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_Genetics, Gene & Cell Therapy Companies
Purespring Therapeutics
Organization & Developments: Purespring Therapeutics
Parents
Purespring Therapeutics
Children
*Purespring is the first company to successfully treat kidney disease models by directly targeting the podocyte, a specialised cell implicated in approximately 60% of renal diseases, through its proprietary adeno-associated viral (AAV) gene therapy platform.
*Purespring’s platform technology allows working copies of genes to be delivered with high efficiency and specificity to podocytes, opening up a new and highly differentiated modality for disease modifying treatments of a broad range of kidney diseases.
The first gene therapy platform to specifically target kidney diseases.
Jumps
Finance & Acquisitions: Purespring Therapeutics
Key People: Purespring Therapeutics